TYCC
Texas Yale Capital Corp’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,000
| Closed | -$255K | – | 454 |
|
|
2024
Q1 | $255K | Hold |
10,000
| – | – | 0.01% | 399 |
|
|
2023
Q4 | $90.5K | Hold |
10,000
| – | – | ﹤0.01% | 420 |
|
|
2023
Q3 | $63.8K | Hold |
10,000
| – | – | ﹤0.01% | 410 |
|
|
2023
Q2 | $111K | Hold |
10,000
| – | – | 0.01% | 425 |
|
|
2023
Q1 | $154K | Hold |
10,000
| – | – | 0.01% | 431 |
|
|
2022
Q4 | $222K | Hold |
10,000
| – | – | 0.01% | 416 |
|
|
2022
Q3 | $163K | Hold |
10,000
| – | – | 0.01% | 424 |
|
|
2022
Q2 | $145K | Hold |
10,000
| – | – | 0.01% | 423 |
|
|
2022
Q1 | $185K | Hold |
10,000
| – | – | 0.01% | 437 |
|
|
2021
Q4 | $238K | Hold |
10,000
| – | – | 0.01% | 406 |
|
|
2021
Q3 | $246K | Hold |
10,000
| – | – | 0.01% | 399 |
|
|
2021
Q2 | $247K | Hold |
10,000
| – | – | 0.01% | 401 |
|
|
2021
Q1 | $218K | Buy |
+10,000
| New | +$218K | 0.01% | 414 |
|